Public, NASDAQ:CYCC
NASDAQ Global Market
Cyclacel Pharmaceuticals (CYCC) Price Soars Above the 50-Day Moving Average
Date: Mon, 06 Feb 2012 23:39:05 GMT
Tags:
Cyclacel Pharmaceuticals (CYCC) Price Soars Above the 50-Day Moving Average
AVAFIN - 16 hours ago
AVAFIN - 16 hours ago
NEW YORK (AVAFIN) -- On Monday shares of Cyclacel Pharmaceuticals closed above the 50-day moving average of $0.58. This development is relevant given that it may be viewed as a sign of strength from a technical perspective.
Cyclacel to Present at Upcoming Investor Conferences
Date: Mon, 06 Feb 2012 14:27:22 GMT
Tags:
Cyclacel to Present at Upcoming Investor Conferences
Broadcast Newsroom - Feb 6, 2012
Broadcast Newsroom - Feb 6, 2012
BERKELEY HEIGHTS, NJ, Feb. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that Spiro Rombotis, President and Chief Executive Officer, will present an update on the ...
Equities Research Analysts' Downgrades for February, 2nd (AKS, ALV, ANN, ASML ...
Date: Thu, 02 Feb 2012 17:09:47 GMT
Tags:
Equities Research Analysts' Downgrades for February, 2nd (AKS, ALV, ANN, ASML ...
LocalizedUSA - Feb 2, 2012
LocalizedUSA - Feb 2, 2012
AK Steel Holding Co. (NYSE: AKS) was downgraded by analysts at Bank of America from a “neutral” rating to an “underperform” rating.
Cyclacel Pharmaceuticals (CYCC) Downgraded by Zacks Investment Research
Date: Thu, 02 Feb 2012 13:35:36 GMT
Tags:
Cyclacel Pharmaceuticals (CYCC) Downgraded by Zacks Investment Research
LocalizedUSA - Feb 2, 2012
LocalizedUSA - Feb 2, 2012
Cyclacel Pharmaceuticals (NASDAQ: CYCC) was downgraded by Zacks Investment Research from an “outperform” rating to a “neutral” rating in a research note issued on Thursday.
CYCLACEL PHARMACEUTICALS INC. : Cyclacel Provides Corporate Update at ...
Date: Wed, 11 Jan 2012 17:36:31 GMT
Tags:
CYCLACEL PHARMACEUTICALS INC. : Cyclacel Provides Corporate Update at ...
4-traders (press release) - Jan 11, 2012
4-traders (press release) - Jan 11, 2012
BERKELEY HEIGHTS, NJ, Jan. 11, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth the Company's key business objectives for 2012 in a ...
Cyclacel to Present at Upcoming Investor Conferences
Date: Mon, 06 Feb 2012 12:00:00 GMT
Tags:
[GlobeNewswire] - BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel" or the "Company") announced today that Spiro Rombotis, President and Chief Executive Officer, will present an update ...
Cyclacel Provides Corporate Update at OneMedForum Conference
Date: Wed, 11 Jan 2012 17:15:00 GMT
Tags:
[GlobeNewswire] - BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth the Company's key business objectives for ...
Cyclacel Provides Corporate Update at OneMedForum Conference
Date: Wed, 11 Jan 2012 17:15:00 GMT
Tags:
[GlobeNewswire] - BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel" or the "Company") today summarized its 2011 achievements and set forth the Company's key business objectives for ...
CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders
Date: Fri, 06 Jan 2012 22:02:07 GMT
Tags:
Cyclacel to Present at the 5th Annual OneMedForum in San Francisco
Date: Fri, 06 Jan 2012 12:00:00 GMT
Tags:
[GlobeNewswire] - BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. ("Cyclacel" or the "Company") today announced that Spiro Rombotis, President and Chief Executive Officer, will review the Company's ...